陈雪红重症病毒性肺炎合并侵袭性真菌感染早期诊断的现状、问题和对策

中国真菌学杂志　 2020, Vol. 15 　Issue (3): 189-192.

综述上一篇

陈雪红重症病毒性肺炎合并侵袭性真菌感染早期诊断的现状、问题和对策

张园¹, 杜君洋¹, 李绘宇¹, 付彦凯¹, 粟艳¹, 周泽奇¹, 王瑶^2,3, 徐英春^2,3, 王贺¹

1. "侵袭性真菌病机制研究与精准诊断"北京市重点实验室丹娜生物分中心, 天津 300467;
2. 中国医学科学院北京协和医院检验科, 北京 100730;
3. "侵袭性真菌病机制研究与精准诊断"北京市重点实验室(BZ0447), 北京 100730

收稿日期:2020-03-16 出版日期:2020-06-28 发布日期:2020-06-28
通讯作者: 王贺,E-mail:wanghe@dynamiker.com E-mail:wanghe@dynamiker.com
作者简介:张园,女(汉族),博士.E-mail:zhangyuan@dynamiker.com
基金资助:
国家科技重大专项"艾滋病和病毒性肝炎等重大传染病防治"课题（编号2020ZX101015）；天津市重大科技专项"新型冠状病毒感染应急防治"课题（编号20ZXGBSY00040）

Received:2020-03-16 Online:2020-06-28 Published:2020-06-28

摘要/Abstract

关键词: COVID-19, 重型/危重型, 侵袭性真菌感染, 血清学联合诊断

中图分类号:

R563.1
R519

张园, 杜君洋, 李绘宇, 付彦凯, 粟艳, 周泽奇, 王瑶, 徐英春, 王贺. 陈雪红重症病毒性肺炎合并侵袭性真菌感染早期诊断的现状、问题和对策[J]. 中国真菌学杂志, 2020, 15(3): 189-192.

[1] Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019(COVID-19) outbreak in China:summary of a report of 72314 cases from the chinese center for disease control and prevention[J]. JAMA, 2020.doi:10.1001/jama.2020.2648.
[2] 阴赪宏, 王超, 汤哲, 等. 146例成人重症SARS的临床分析[J]. 中华急诊医学杂志, 2004, 13(1):12-14.
[3] 郑毅, 李文雄, 黄克武, 等. 重症SARS患者急性期后院内获得性肺炎[J]. 中华医院感染学杂志, 2003, 13(11):85-87+21.
[4] Vanderbeke L, Spriet I, Breynaert C, et al. Invasive pulmonary aspergillosis complicating severe influenza:epidemiology, diagnosis and treatment[J]. Curr Opin Infect Dis, 2018,31(6):471-480.
[5] Schauwvlieghe A, Rijnders BJA, Philips N, et al. Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza:a retrospective cohort study[J]. Lancet Respir Med, 2018,6(10):782-792.
[6] Van de Veerdonk FL, Kolwijck E, Lestrade PP, et al. Influenza-Associated Aspergillosis in Critically Ill Patients[J]. Am J Respir Crit Care Med, 2017,196(4):524-527.
[7] Martin-Loeches I, M JS, Vincent JL, et al. Increased incidence of co-infection in critically ill patients with influenza[J]. Intensive Care Med, 2017,43(1):48-58.
[8] Wauters J, Baar I, Meersseman P, et al. Invasive pulmonary aspergillosis is a frequent complication of critically ill H1N1 patients:a retrospective study[J]. Intensive Care Med, 2012,38(11):1761-1768.
[9] Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China:a descriptive study[J]. Lancet, 2020,395(10223):507-513.
[10] Yang XB, Yu Y, Xu JQ, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China:a single-centered, retrospective, observational study[J]. Lancet Respir Med, 2020, 8(5):475-481.
[11] 胡明.直播精华|胡明:武汉市肺科医院ICU重症新冠肺炎诊治经验-阻击新冠权威在线.呼吸界[OL]. 2020-02-11[2020-02-11]. http://www.360doc.com/content/20/0211/09/10128319_891195797.shtml.
[12] 徐凯进, 蔡洪流, 沈毅弘, 等. 2019冠状病毒病(COVID-19)诊疗浙江经验[J]. 浙江大学学报(医学版),2020,49(2):147-157.
[13] McCullers JA. The co-pathogenesis of influenza viruses with bacteria in the lung[J]. Nat Rev Microbiol, 2014,12(4):252-262.
[14] Nguyen MH, Wissel MC, Shields RK, et al. Performance of Candida real-time polymerase chain reaction, beta-D-glucan assay, and blood cultures in the diagnosis of invasive candidiasis[J]. Clin Infect Dis, 2012,54(9):1240-1248.
[15] Baddley JW, Andes DR, Marr KA, et al. Factors associated with mortality in transplant patients with invasive aspergillosis[J]. Clin Infect Dis, 2010,50(12):1559-1567.
[16] Park BJ, Pappas PG, Wannemuehler KA, et al. Invasive non-Aspergillus mold infections in transplant recipients, United States, 2001-2006[J]. Emerg Infect Dis, 2011,17(10):1855-1864.
[17] Walsh TJ, Anaissie EJ, Denning DW, et al. Treatment of aspergillosis:clinical practice guidelines of the Infectious Diseases Society of America[J]. Clin Infect Dis, 2008,46(3):327-360.
[18] Ullmann AJ, Cornely OA, Donnelly JP, et al. ESCMID* guideline for the diagnosis and management of Candida diseases 2012:developing European guidelines in clinical microbiology and infectious diseases[J]. Clin Microbiol Infect, 2012, 18(Suppl 7):1-8.
[19] Patterson TF, Thompson GR 3rd, Denning DW, et al. Practice guidelines for the diagnosis and management of aspergillosis:2016 update by the Infectious Diseases Society of America[J]. Clin Infect Dis, 2016,63(4):e1-e60.
[20] Onishi A, Sugiyama D, Kogata Y, et al. Diagnostic accuracy of serum 1,3-beta-D-glucan for pneumocystis jiroveci pneumonia, invasive candidiasis, and invasive aspergillosis:systematic review and meta-analysis[J]. J Clin Microbiol, 2012,50(1):7-15.
[21] Karageorgopoulos DE, Qu JM, Korbila IP, et al. Accuracy of beta-D-glucan for the diagnosis of Pneumocystis jirovecii pneumonia:a meta-analysis[J]. Clin Microbiol Infect, 2013,19(1):39-49.
[22] 中国成人念珠菌病诊断与治疗专家共识组.中国成人念珠菌病诊断与治疗专家共识[J]. 中国医学前沿杂志(电子版),2020,12(1):35-50.
[23] Donnelly JP, Chen SC, Kauffman CA, et al. Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium[J]. Clin Infect Dis, 2019, doi:10.1093/cid/ciz1008.
[24] Denning DW, Cadranel J, Beigelman-Aubry C, et al. Chronic pulmonary aspergillosis:rationale and clinical guidelines for diagnosis and management[J]. Eur Respir J, 2016,47(1):45-68.
[25] Page ID, Richardson M, Denning DW. Antibody testing in aspergillosis-quo vadis[J]? Med Mycol, 2015,53(5):417-439.
[26] Guo Y, Bai Y, Yang C, et al. Evaluation of Aspergillus IgG, IgM antibody for diagnosing in chronic pulmonary aspergillosis:A prospective study from a single center in China[J]. Medicine (Baltimore), 2019,98(16):e15021.
[27] Li H, Rui Y, Zhou W, et al. Role of the Aspergillus-specific IgG and IgM test in the diagnosis and follow-up of chronic pulmonary aspergillosis[J]. Front Microbiol, 2019,10:1438.
[28] Ma X, Wang K, Zhao X, et al. Prospective study of the serum Aspergillus-specific IgG, IgA and IgM assays for chronic pulmonary aspergillosis diagnosis[J]. BMC Infect Dis, 2019,19(1):694.
[29] Ahmad S, Khan Z. Invasive candidiasis:a review of nonculture-based laboratory diagnostic methods[J]. Indian J Med Microbiol, 2012,30(3):264-269.
[30] Li F, Yu X, Ye L, et al. Clinical value of (1,3)-beta-D-glucan, mannan, antimannan IgG and IgM antibodies in diagnosis of invasive candidiasis[J]. Med Mycol, 2019,57(8):976-986.
[31] Mikulska M, Calandra T, Sanguinetti M, et al. The use of mannan antigen and anti-mannan antibodies in the diagnosis of invasive candidiasis:recommendations from the Third European Conference on Infections in Leukemia[J]. Crit Care, 2010,14(6):R222.
[32] Marchetti O, Lamoth F, Mikulska M, et al. ECIL recommendations for the use of biological markers for the diagnosis of invasive fungal diseases in leukemic patients and hematopoietic SCT recipients[J]. Bone Marrow Transplant, 2012,47(6):846-854.

陈雪红重症病毒性肺炎合并侵袭性真菌感染早期诊断的现状、问题和对策

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	丁翔宇, 贾晨虹, 张古英, 李倩, 刘艳辉. 普外科婴幼儿侵袭性真菌感染的高危因素分析与评分系统建立[J]. 中国真菌学杂志, 2020, 15(6): 331-337,353.
[2]	霍晓赛, 贺政新, 王缚鲲. 侵袭性念珠菌感染及其与定植的关系研究进展[J]. 中国真菌学杂志, 2020, 15(2): 125-128.
[3]	陈伟, 张晓梅, 万喆, 李若瑜, 余进, 王爱平, 刘伟. 抗击COVID-19感染病原性真菌实验室生物安全防护建议(试行)[J]. 中国真菌学杂志, 2020, 15(1): 6-9.
[4]	范欣, 郭莉娜, 杨洋, 张戈, 段思蒙, 张京家, 徐英春, 杨春霞. 侵袭性感染酵母菌流行病学及耐药性分析[J]. 中国真菌学杂志, 2020, 15(1): 10-14.
[5]	左微, 肖青. 恶性血液肿瘤患者侵袭性真菌感染防治进展[J]. 中国真菌学杂志, 2018, 13(4): 252-256.
[6]	尚元元, 喻楠, 董灵娣, 李莎莎, 刘昱奚. 血浆(1-3)-β-D葡聚糖对院内侵袭性真菌感染诊断的临床价值[J]. 中国真菌学杂志, 2018, 13(3): 168-172.
[7]	徐明均, 张慧婷, 张玉洁, 徐玉洁, 孙小鹏, 马晓薇. 血浆1,3-β-D葡聚糖检测联合念珠菌评分对侵袭性真菌感染的诊断价值[J]. 中国真菌学杂志, 2018, 13(1): 11-14.
[8]	郭凯, 项珍珍, 桑军军, 陈莉. 烟曲霉播散性感染1例误诊分析[J]. 中国真菌学杂志, 2016, 11(6): 372-375.
[9]	黄劲龙, 肖世极, 田丽红, 张媛媛, 周华蓉, 沈建箴. 泊沙康唑预防侵袭性真菌感染的Meta分析[J]. 中国真菌学杂志, 2015, 10(6): 357-364.
[10]	王学莉, 伏添, 王成立, 胡文能, 张西京. 两性霉素B治疗侵袭性肺部真菌感染的临床分析[J]. 中国真菌学杂志, 2014, 9(3): 163-166.
[11]	刘耀婷, 陈险峰, 胡海清, 殷杏, 陈勇, 周庭银, 仲人前. 血浆(1,3)-β-D葡聚糖检测对器官移植患者侵袭性真菌感染诊断价值[J]. 中国真菌学杂志, 2013, 8(3): 151-155.
[12]	金丽娜, 杜鹃, 袁振刚, 张春阳, 傅卫军, 侯健. 多发性骨髓瘤并发上消化道侵袭性念珠菌病2例报道及文献复习[J]. 中国真菌学杂志, 2013, 8(2): 83-86.
[13]	郝飞, 王莉, 周村建. 糖皮质激素与侵袭性真菌感染[J]. 中国真菌学杂志, 2012, 7(6): 367-371.
[14]	郝飞. 对深部真菌病使用“侵袭性真菌感染” 诊断名称的质疑[J]. 中国真菌学杂志, 2012, 7(3): 129-131.
[15]	李梦, 廖万清. 侵袭性真菌感染治疗新进展[J]. 中国真菌学杂志, 2012, 7(1): 47-51.